Literature DB >> 19088490

Cognitive performance and grey matter density in psychosis: functional relevance of a structural endophenotype.

P Habets1, L Krabbendam, P Hofman, J Suckling, F Oderwald, E Bullmore, P Woodruff, J Van Os, M Marcelis.   

Abstract

BACKGROUND: Structural brain changes and cognitive impairments have been identified as indicators of genetic risk for schizophrenia. However, the pattern of associations between such structural and functional liability markers has been less well investigated.
METHODS: Magnetic resonance imaging data and cognitive assessments were acquired in 31 patients with psychosis, 32 non-psychotic first-degree relatives and 28 controls. The relationship between cerebral grey matter density and cognitive performance was examined using computational morphometry.
RESULTS: Two out of 6 cognitive tests revealed significant associations with grey matter density in regions of the frontal lobe, basal ganglia, thalamus and cerebellum in patients and relatives. In patients, poorer executive functioning was associated with cerebellar grey matter density deficits. In relatives, poorer executive functioning was associated with increased grey matter density in the cerebellum and frontal lobe. In both patients and relatives, strategic retrieval from semantic memory was positively associated with grey matter density in basal ganglia structures. Some additional negative associations in the patients differentiated this group from relatives.
CONCLUSIONS: The overlap in structure-function relationships in individuals with schizophrenia and those with liability for the disorder may suggest that regional grey matter density alterations functionally alter particular neurocircuits, which could lead to cognitive deficits. The non-overlapping structure-function correlations may reflect disease-related or compensatory mechanisms. 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19088490     DOI: 10.1159/000182889

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  5 in total

Review 1.  Cognitive control deficits in schizophrenia: mechanisms and meaning.

Authors:  Tyler A Lesh; Tara A Niendam; Michael J Minzenberg; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2010-09-15       Impact factor: 7.853

2.  Neurocognitive Impairments in Unaffected First-degree Relatives of Schizophrenia.

Authors:  Virupaksha Shanmugam Harave; Venkataram Shivakumar; Sunil V Kalmady; Janardhanan C Narayanaswamy; Shivarama Varambally; Ganesan Venkatasubramanian
Journal:  Indian J Psychol Med       Date:  2017 May-Jun

3.  CamBAfx: Workflow Design, Implementation and Application for Neuroimaging.

Authors:  Cinly Ooi; Edward T Bullmore; Alle-Meije Wink; Levent Sendur; Anna Barnes; Sophie Achard; John Aspden; Sanja Abbott; Shigang Yue; Manfred Kitzbichler; David Meunier; Voichita Maxim; Raymond Salvador; Julian Henty; Roger Tait; Naresh Subramaniam; John Suckling
Journal:  Front Neuroinform       Date:  2009-08-28       Impact factor: 4.081

4.  An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use.

Authors:  Else-Marie Løberg; Merethe Nygård; Jan Øystein Berle; Erik Johnsen; Rune A Kroken; Hugo A Jørgensen; Kenneth Hugdahl
Journal:  Front Psychiatry       Date:  2012-10-30       Impact factor: 4.157

5.  Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis.

Authors:  Naksidil Torun Yazıhan; Sinan Yetkin
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.